《大行報告》花旗下調蒙牛(02319.HK)目標價至39.7元 評級「買入」
花旗發表研報,將蒙牛(02319.HK)2023至2025年銷售預測下調4%、5%及5%,調整後目前預計今年全年銷售額將按年增長8%,符合管理層全年銷售額內生增長率達中單位數、整體銷售額增由達高單位數的預期。
同時,花旗亦將蒙牛2023至2025年淨利潤預測下調7%、7%及8%,維持未來三年息稅前利潤率按年提升50個基點的預期,基於今年預測市盈率約25倍,相應將目標價從45.5元下調至39.7元,並維持「買入」評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.